Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Asset Writedowns and Impairment (2017 - 2019)

Mesa Laboratories (MLAB) has disclosed Asset Writedowns and Impairment for 3 consecutive years, with $276000.0 as the latest value for Q4 2019.

  • Quarterly Asset Writedowns and Impairment fell 92.48% to $276000.0 in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $5.0 million through Mar 2020, down 72.84% year-over-year, with the annual reading at $274.5 million for FY2024, N/A changed from the prior year.
  • Asset Writedowns and Impairment hit $276000.0 in Q4 2019 for Mesa Laboratories, down from $1.1 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $13.8 million in Q4 2017 to a low of $276000.0 in Q4 2019.
  • Historically, Asset Writedowns and Impairment has averaged $4.7 million across 3 years, with a median of $2.4 million in 2018.
  • Biggest five-year swings in Asset Writedowns and Impairment: tumbled 73.45% in 2018 and later plummeted 92.48% in 2019.
  • Year by year, Asset Writedowns and Impairment stood at $13.8 million in 2017, then crashed by 73.45% to $3.7 million in 2018, then tumbled by 92.48% to $276000.0 in 2019.
  • Business Quant data shows Asset Writedowns and Impairment for MLAB at $276000.0 in Q4 2019, $1.1 million in Q1 2019, and $3.7 million in Q4 2018.